You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Qlife - LOI with major industry player in China for Egoo Health
Meet and ask questions to CEO Thomas Warthoe from Qlife on 19 September 2023 at 9.00 AM.
Qlife announced that they have signed a Letter of Intent (LOI) with major industry player, Hipro Biotechnology, to introduce Egoo Health to the Chinese market. Qlife anticipate finalizing a comprehensive collaboration agreement by the end of this year.
Disclaimer: HC Andersen Capital receives payment from Qlife Holding for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 14-09-2023 4.39PM.
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
Vis alle videoer